Global system for cancer drug testing and approval is needed
Cancer · 2023
DOI: 10.1002/cncr.34668 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2023. Verfasst von Mary Beth Nierengarten. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, physicians make a case for the value of creating a global system for cancer drug testing and approval. In addition, a new study shows that regular physical activity may help patients with colorectal cancer by maintaining a healthy gut microbiome, and accelerated approval was granted for targeted therapy for platinum‐resistant gynecologic cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Nierengarten, M. B. (2023). Global system for cancer drug testing and approval is needed. Cancer. https://doi.org/10.1002/cncr.34668
Vancouver
Nierengarten MB. Global system for cancer drug testing and approval is needed. Cancer. 2023. doi:10.1002/cncr.34668
BibTeX
@article{Nierengarten2023,
author = {Nierengarten, Mary Beth},
title = {Global system for cancer drug testing and approval is needed},
journal = {Cancer},
year = {2023},
doi = {10.1002/cncr.34668}
}
EUVIMED